ID

37770

Description

Study ID: 104864/627 Clinical Study ID: 104864/627 Study Title: An Open-label, Multicenter, Non-Comparative Phase II Study of the Combination of Intravenous Topotecan and Gemcitabine Administered Once Weekly for Three Weeks Every 28 Days as Second-line Treatment in Patients With Recurrent Platinum Sensitive Ovarian Cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00061308 Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Topotecan, Gemcitabine Study Indication: Peritoneal Cancer, Ovarian Cancer, Neoplasms, Ovarian, Fallopian Tube Cancer

Keywords

  1. 8/22/19 8/22/19 -
  2. 8/23/19 8/23/19 -
Copyright Holder

GlaxoSmithKline

Uploaded on

August 23, 2019

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Intravenous Topotecan and Gemcitabine as Second-line Treatment in Patients With Ovarian Cancer NCT00061308

Screening - Significant Medical/ Surgical History and Physical Examination; History of Ovarian Cancer; Tumor Marker

Administrative
Description

Administrative

Alias
UMLS CUI-1
C1320722
Center Number
Description

Center Number

Data type

text

Alias
UMLS CUI [1,1]
C1301943
UMLS CUI [1,2]
C0600091
Patient Number
Description

Patient Number

Data type

text

Alias
UMLS CUI [1]
C1709561
Patient ID
Description

Patient ID

Data type

text

Alias
UMLS CUI [1]
C2348585
Significant Medical/ Surgical History and Physical Examination
Description

Significant Medical/ Surgical History and Physical Examination

Alias
UMLS CUI-1
C0262926
UMLS CUI-2
C0489540
UMLS CUI-3
C0031809
Is the patient suffering from or has she ever suffered from any significant medical or surgical condition not related to the study indication?
Description

If ”Yes“, please provide diagnosis below listing no more than one diagnosis per line.

Data type

boolean

Alias
UMLS CUI [1]
C0543467
UMLS CUI [2]
C0012634
UMLS CUI [3,1]
C2603343
UMLS CUI [3,2]
C3146298
UMLS CUI [3,3]
C0439849
Significant Medical/ Surgical History and Physical Examination
Description

Significant Medical/ Surgical History and Physical Examination

Alias
UMLS CUI-1
C0262926
UMLS CUI-2
C0489540
UMLS CUI-3
C0031809
Diagnosis
Description

Diagnosis

Data type

text

Alias
UMLS CUI [1]
C0011900
Date of Diagnosis
Description

Date of Diagnosis

Data type

partialDate

Alias
UMLS CUI [1]
C2316983
Status of Disease
Description

Status of Disease

Data type

integer

Alias
UMLS CUI [1]
C0699749
History of Ovarian Cancer
Description

History of Ovarian Cancer

Alias
UMLS CUI-1
C0029925
UMLS CUI-2
C0262926
Date of Original Diagnosis
Description

Date of Original Diagnosis

Data type

date

Alias
UMLS CUI [1]
C2316983
Date of Relapse
Description

Date of Relapse

Data type

date

Alias
UMLS CUI [1,1]
C0035020
UMLS CUI [1,2]
C0011008
Primary Tumor Diagnosis
Description

(please choose one)

Data type

integer

Alias
UMLS CUI [1,1]
C0677930
UMLS CUI [1,2]
C0011900
Please record the current TNM stage of the patient
Description

Please record the current TNM stage of the patient

Data type

text

Alias
UMLS CUI [1]
C1302362
FIGO Stage of current disease
Description

(please choose one) NOTE: Patient is ONL Y eligible if she is stage IIIB, IIIC or IV.

Data type

integer

Alias
UMLS CUI [1]
C0450454
Metastatic
Description

Metastatic

Alias
UMLS CUI-1
C0027627
Metastasis - Date of Diagnosis
Description

Metastasis - Date of Diagnosis

Data type

date

Alias
UMLS CUI [1,1]
C2316983
UMLS CUI [1,2]
C0027627
Metastasis - Site
Description

Metastasis - Site

Data type

integer

Alias
UMLS CUI [1]
C0807944
If other site of metastasis, specify.
Description

If other site of metastasis, specify.

Data type

text

Alias
UMLS CUI [1,1]
C0807944
UMLS CUI [1,2]
C0205394
UMLS CUI [1,3]
C2348235
Tumor Marker (CA-125) (7 days prior to Day 1)
Description

Tumor Marker (CA-125) (7 days prior to Day 1)

Alias
UMLS CUI-1
C0474700
UMLS CUI-2
C0201549
Sample Date
Description

Sample Date

Data type

date

Alias
UMLS CUI [1]
C1302413
Laboratory Name
Description

Laboratory Name

Data type

text

Alias
UMLS CUI [1]
C3258037
CA-125 Value
Description

CA-125 Value

Data type

integer

Measurement units
  • U/mL
Alias
UMLS CUI [1]
C0201549
U/mL

Similar models

Screening - Significant Medical/ Surgical History and Physical Examination; History of Ovarian Cancer; Tumor Marker

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Administrative
C1320722 (UMLS CUI-1)
Center Number
Item
Center Number
text
C1301943 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Patient Number
Item
Patient Number
text
C1709561 (UMLS CUI [1])
Patient ID
Item
Patient ID
text
C2348585 (UMLS CUI [1])
Item Group
Significant Medical/ Surgical History and Physical Examination
C0262926 (UMLS CUI-1)
C0489540 (UMLS CUI-2)
C0031809 (UMLS CUI-3)
Is the patient suffering from or has she ever suffered from any significant medical or surgical condition not related to the study indication?
Item
Is the patient suffering from or has she ever suffered from any significant medical or surgical condition not related to the study indication?
boolean
C0543467 (UMLS CUI [1])
C0012634 (UMLS CUI [2])
C2603343 (UMLS CUI [3,1])
C3146298 (UMLS CUI [3,2])
C0439849 (UMLS CUI [3,3])
Item Group
Significant Medical/ Surgical History and Physical Examination
C0262926 (UMLS CUI-1)
C0489540 (UMLS CUI-2)
C0031809 (UMLS CUI-3)
Diagnosis
Item
Diagnosis
text
C0011900 (UMLS CUI [1])
Date of Diagnosis
Item
Date of Diagnosis
partialDate
C2316983 (UMLS CUI [1])
Item
Status of Disease
integer
C0699749 (UMLS CUI [1])
Code List
Status of Disease
CL Item
Past (1)
CL Item
Current/ Active (2)
Item Group
History of Ovarian Cancer
C0029925 (UMLS CUI-1)
C0262926 (UMLS CUI-2)
Date of Original Diagnosis
Item
Date of Original Diagnosis
date
C2316983 (UMLS CUI [1])
Date of Relapse
Item
Date of Relapse
date
C0035020 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item
Primary Tumor Diagnosis
integer
C0677930 (UMLS CUI [1,1])
C0011900 (UMLS CUI [1,2])
Code List
Primary Tumor Diagnosis
CL Item
Epithelial ovarian carcinoma  (1)
CL Item
Primary peritoneal carcinoma  (2)
CL Item
Fallopian tube carcinoma  (3)
CL Item
Tumors of mixed mullerian origin (4)
Please record the current TNM stage of the patient
Item
Please record the current TNM stage of the patient
text
C1302362 (UMLS CUI [1])
Item
FIGO Stage of current disease
integer
C0450454 (UMLS CUI [1])
Code List
FIGO Stage of current disease
CL Item
IIIB Macroscopic peritoneal metastasis beyond pelvis 2 cm or less in greatest dimension.  (1)
CL Item
IIIC Peritoneal metastasis beyond pelvis more than 2 cm in greatest dimension and/or regional lymph node metastasis.  (2)
CL Item
IV Distant metastasis (excludes peritoneal metastasis). (3)
Item Group
Metastatic
C0027627 (UMLS CUI-1)
Metastasis - Date of Diagnosis
Item
Metastasis - Date of Diagnosis
date
C2316983 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
Item
Metastasis - Site
integer
C0807944 (UMLS CUI [1])
Code List
Metastasis - Site
CL Item
Lymph Node  (1)
CL Item
Liver  (2)
CL Item
Other, Specify. (3)
If other site of metastasis, specify.
Item
If other site of metastasis, specify.
text
C0807944 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
Item Group
Tumor Marker (CA-125) (7 days prior to Day 1)
C0474700 (UMLS CUI-1)
C0201549 (UMLS CUI-2)
Sample Date
Item
Sample Date
date
C1302413 (UMLS CUI [1])
Laboratory Name
Item
Laboratory Name
text
C3258037 (UMLS CUI [1])
CA-125 Value
Item
CA-125 Value
integer
C0201549 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial